Filing metadata

Accession number
0001415889-25-021066
Form type
Form 4
Filer
Aurinia Pharmaceuticals Inc.
CIK
CIK 1600620
Filed
Aug 05, 2025
Reporting period
Aug 01, 2025
Description
Insider transaction

Explore SEC Filings Hub